Skip to main content
. 2012 Mar 5;2(3):e29. doi: 10.1038/nutd.2012.1

Figure 6.

Figure 6

Summary of the whole-body effects of TGF-β/Smad3 signaling in obesity-linked diabetes and how blockage of TGF-β/Smad3 signaling ameliorates obesity and type 2 diabetes.

HHS Vulnerability Disclosure